For instance, studies have shown that miR-539-5p from MSC-Exos can target NLRP3 in intestinal epithelial cells, modulating the process of pyroptosis in a mouse model of inflammatory bowel disease (IBD), thereby alleviating the progression of IBD (106). This evidence concerns the gene NLRP3 and inflammatory bowel disease.